发明授权
- 专利标题: Engineered CXCL12 α locked dimer polypeptide
- 专利标题(中): 工程化CXCL12α锁定二聚体多肽
-
申请号: US12380308申请日: 2009-02-26
-
公开(公告)号: US07923016B2公开(公告)日: 2011-04-12
- 发明人: Brian F. Volkman , Christopher T. Veldkamp , Francis C. Peterson , Thomas Sakmar , Christoph H. Seibert
- 申请人: Brian F. Volkman , Christopher T. Veldkamp , Francis C. Peterson , Thomas Sakmar , Christoph H. Seibert
- 申请人地址: US WI Milwaukee US NY New York
- 专利权人: Medical College of Wisconsin,Rockefeller University
- 当前专利权人: Medical College of Wisconsin,Rockefeller University
- 当前专利权人地址: US WI Milwaukee US NY New York
- 代理机构: Quarles & Brady, LLP
- 主分类号: A61K38/19
- IPC分类号: A61K38/19 ; C07K14/435
摘要:
The present invention provides a novel CXCL12-α2 locked dimer polypeptide, pharmaceutical compositions thereof, and methods of using said dimer in the treatment of cancer, inflammatory disorders, autoimmune disease, and HIV/AIDS.
公开/授权文献
- US20090305984A1 Engineered CXCL 12 alpha locked dimer polypeptide 公开/授权日:2009-12-10